Emosis’ HIT Diagnostic Test Approved for Marketing by EC

The European Commission granted Emosis’ heparin-induced thrombocytopenia (HIT) diagnostic test a CE Mark.

The flow cytometry-based HIT Confirm test provides results in a half hour by reading selected platelet biomarkers.

The test can contribute to the diagnosis of potentially lethal HIT in patients treated by the anticoagulant.